Literature DB >> 10388876

Healing large tympanic membrane perforations using hyaluronic acid, basic fibroblast growth factor, and epidermal growth factor.

K Chauvin1, C Bratton, C Parkins.   

Abstract

Large tympanic membrane perforations usually require a surgical tympanoplasty for closure. Reducing surgical costs and risks has encouraged investigators to examine nonsurgical office procedures for healing these perforations. Growth accelerators are the most promising agents. We study here the closure of large acute perforations using weekly applications of 1 mg of 1% hyaluronic acid (HA), 0.4 microg basic fibroblast growth factor (bFGF), or 1.0 microg epidermal growth factor (EGF) directly to the tympanic membranes of the experimental ears. Control ears were treated with 0. 1 mL Vasocidin. Complete closure was obtained in 100% of the ears treated with HA and EGF and 85.7% of those treated with bFGF by day 21, compared with 63.6% of the controls by day 32. Moderate-to-severe ipsilateral and contralateral external canal hypertrophy was noted in 14.2% and 37.5% of the ears treated with bFGF and HA, respectively, but was not seen in ears treated with EGF or in the control group.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10388876     DOI: 10.1016/S0194-5998(99)70122-1

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  19 in total

1.  [An improved animal model for chronic perforation of the tympanic membrane].

Authors:  H Kaftan; W Hosemann; A Beule; D Junghans
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

2.  Biocompatibility evaluation of cigarette and carbon papers used in repair of traumatic tympanic membrane perforations: experimental study.

Authors:  Emine Elif Altuntaş; Zeynep Sümer
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-24       Impact factor: 2.503

3.  Keratinocyte growth factor 1, fibroblast growth factor 2 and 10 in the healing tympanic membrane following perforation in rats.

Authors:  Peter L Santa Maria; Sharon L Redmond; Marcus D Atlas; Reza Ghassemifar
Journal:  J Mol Histol       Date:  2010-12-07       Impact factor: 2.611

4.  [Fibrin gel for treatment of tympanic membrane perforations: an experimental animal model].

Authors:  H Kaftan; D Eyrich; E Schindler; A Göpferich; W Hosemann
Journal:  HNO       Date:  2006-12       Impact factor: 1.284

5.  Functional Outcomes of Heparin-Binding Epidermal Growth Factor-Like Growth Factor for Regeneration of Chronic Tympanic Membrane Perforations in Mice.

Authors:  Peter Luke Santa Maria; Peter Gottlieb; Chloe Santa Maria; Sungwoo Kim; Sunil Puria; Yunzhi Peter Yang
Journal:  Tissue Eng Part A       Date:  2017-02-24       Impact factor: 3.845

6.  Heparin binding-epidermal growth factor-like growth factor for the regeneration of chronic tympanic membrane perforations in mice.

Authors:  Peter Luke Santa Maria; Sungwoo Kim; Yasin Kursad Varsak; Yunzhi Peter Yang
Journal:  Tissue Eng Part A       Date:  2015-03-17       Impact factor: 3.845

7.  Regeneration of chronic tympanic membrane perforation using an EGF-releasing chitosan patch.

Authors:  Hoon Seonwoo; Seung Won Kim; Jangho Kim; Tian Chunjie; Ki Taek Lim; Yeon Ju Kim; Shambhavi Pandey; Pill-Hoon Choung; Yun-Hoon Choung; Jong Hoon Chung
Journal:  Tissue Eng Part A       Date:  2013-09       Impact factor: 3.845

8.  Hyaluronic acid fat graft myringoplasty vs fat patch fat graft myringoplasty.

Authors:  Musaed Alzahrani; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-15       Impact factor: 2.503

9.  "Dry", "moist", and "wet" status of the middle ear in the regeneration of the eardrum.

Authors:  Shan-Fang Song; Qing Hao; Peng Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-26       Impact factor: 2.503

10.  [Traumatic tympanic membrane perforactions. Local application of an alginate matrix loaded with epidermal growth factor in an animal model].

Authors:  H Kaftan; W Hosemann; D Junghans; A Göpferich; E Schindler; A Beule
Journal:  HNO       Date:  2005-06       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.